2021 Archive

Research

Laying the foundation for neuronal development

Brian O'Flynn, PhD

See how blocking one kinase resulted in premature neuron growth

Investigator Insights

5 Questions for Renato Umeton, PhD

Renato Umeton, PhD and Alex Generous, PhD

Meet St. Jude Chief of AI Renato Umeton, PhD, Office of Data Science.

Outreach

Working globally to save critically ill children with cancer

LaToyia P. Downs, PhD

The Global Critical Care Program is advancing critical care for children with cancer worldwide through innovation, collaboration and education.

Investigator Insights

5 Questions for Anand Kulkarni, PhD

Erin Podolak, MA and Anand Kulkarni, PhD

Learn what associate scientist Anand Kulkarni, PhD, thinks makes doing research at St. Jude different from anywhere else.

Clinical

Research findings set the stage for GLOBOTRK, a clinical trial with targeted therapy for NTRK and ROS1 fusions

Alex Generous, PhD

St. Jude is leading a global clinical trial for brain tumors.

Investigator Insights

5 Questions for Janeala Morsby, PhD

Erin Podolak, MA and Janeala Morsby, PhD

Meet postdoctoral researcher Janeala Morsby, PhD, Department of Oncology and learn about her research.

Clinical

Patient voices shape the future of gene therapy

Alex Generous, PhD

Learn what patients, families and health care workers think about gene therapy.

Investigator Insights

5 Questions for Priyanka Dogra, PhD

Priyanka Dogra, PhD and Erin Podolak, MA

Meet postdoctoral researcher Priyanka Dogra, PhD, Department of Structural Biology, and learn about her research.  

Clinical

Hydroxyurea may help kids with sickle cell disease breathe better at night

Alex Generous, PhD

Find how sickle cell treatment may help kids get better sleep.

Investigator Insights

5 Questions for Maowei Hu, PhD

Maowei Hu and Erin Podolak, MA

Meet postdoctoral researcher Maowei Hu, PhD, Department of Chemical Biology & Therapeutics and learn about her research.  

Investigator Insights

Roussel’s early discovery shaped a career of cancer research

St. Jude Communications Department

Martine Roussel, PhD, faculty member and endowed chair in molecular oncogenesis, shares how early work on oncogenes led to her lab’s discovery of new oncogenes.

Research

Identifying risks and restrictions: Rehabilitation and cancer survivorship

St. Jude Communications Department

Kristin Lyons, director of Rehabilitation Services, and Jessica Sparrow, Lead Occupational Therapist, worked as part of a team of oncology rehabilitation providers from pediatric institutions across the country to co-author a recent Seminars in Oncology Nursing article, which provides a comprehensive overview of rehabilitation screening, assessment, and intervention for children with cancer.

Research

Getting to the bottom of a medulloblastoma mystery

Erin Podolak, MA

Posterior fossa syndrome develops in some children following surgery for the brain tumor medulloblastoma. St. Jude research offers fresh insight into the mysterious syndrome and advice on how to avoid it.

Clinical

NCCN publishes guidelines for standardized treatment of Wilms tumor

St. Jude Strategic Communication, Education and Outreach Department

The National Comprehensive Cancer Network recently published treatment guidelines for children diagnosed with nephroblastoma. Two St. Jude physicians collaborated on the project.

Research

For the growing number of childhood cancer survivors, five-year survival is just the beginning

AnnaLynn Williams, PhD

As cancer survivorship changes, new benchmarks must be set to redefine survivorship research and treatment success.

Outreach

Advocating globally for a COVID-19 vaccine

Miguela Caniza, MD, MPH

It’s essential to provide an accurate, science-based website for vaccine information. The St. Jude Global COVID-19 Working Group plans to provide accurate COVID-19 information, including answering questions and providing vaccine news as it emerges.

Outreach

We can – we will – accelerate progress globally

James R. Downing, MD

St. Jude Children’s Research Hospital is launching the largest strategic investment in its nearly 60-year history, committing $11.5 billion during the next six years to accelerate research and treatment globally for children with catastrophic diseases.

Research

The heart of the matter – cancer survivors and heart disease

Matthew J. Ehrhardt, MD

Cancer treatments can result in damage to the heart both during treatment and years following completion of therapy. As many cancer survivors are now living longer into adulthood, we’re gaining a better understanding of some of the late effects of cancer treatments that we weren’t able to observe before.

Research

Immune markers offer clues to antibody production in response to flu

Mary Powers

Scientists are learning more about antibody production in response to flu, including how they develop from helper T cells and monocytes.

Clinical

Cancer care during a pandemic: What we learned prepares us for the next emergency

Dylan Graetz, MD, MPH

The pandemic exposed shortcomings in health care. But this study revealed more than expected in this type of children’s treatment.